Those who have experienced adverse effects from Pradaxa can receive help from Houston Law Firm.
Houston, TX, April 25, 2012—Sullo & Sullo, LLP a Houston law firm providing litigation support for patients who have suffered damages through the use of the drug Pradaxa is offering counsel and knowledgeable advice for those who have a valid Pradaxa-related claim.
Pradaxa came onto the market as the “new kid on the block,” in 2010 for use in patients with atrial fibrillation and to prevent potential strokes. Up until that time one drug—Warfarin—had been used in stroke prevention and the treatment of atrial fibrillation since the 1950’s. While initial studies showed Pradaxa to be the superior drug, mere months after the drug received FDA approval, adverse reports began pouring in. As serious bleeding events began to result from Pradaxa use doctors realized that unlike Warfarin, there was no known antidote to excessive bleeding from Pradaxa.
While both Warfarin and Pradaxa accomplish the same health result, they work in very different ways. Warfarin works by blocking production of Vitamin K in the body, and in the event of excessive bleeding Vitamin K can be given to counteract the bleeding effects. Pradaxa works by inhibiting the production of thrombin which is a naturally occurring enzyme in the blood that controls blood clotting. Pradaxa has no such reversal agent therefore patients can suffer uncontrollable bleeding which in some cases quickly escalates to death. There have been over 260 reported deaths believed to be directly related to Pradaxa as well as other serious health issues including subdural bleeding, intracranial bleeding, gastrointestinal bleeding, pericardial bleeding and even heart attacks.
The goal of Sullo & Sullo, LLP is to protect individuals’ claims regarding adverse effects from Pradaxa while determining the potential for recovery. Because of the very strict statute of limitations regarding product liability cases, injured parties must be very aware of those deadlines. Missing a deadline can cause the permanent relinquishment of the right to bring a lawsuit against Boehringer Ingelheim, the manufacturer of Pradaxa. Managing Partner Andrew Sullo states, “This particular drug has had some very serious and even deadly side effects for a number of its users. We are trying to reach out to those individuals who may have been harmed by this drug and are wondering what to do from here…” In this vein, Sullo & Sullo, LLP hopes to protect the rights of Pradaxa victims while bringing its legal experience and comprehensive knowledge regarding product liability cases to the table.
Contact:
Sullo & Sullo, LLP
Southwest Fwy, Suite 300
Houston, TX 77098
713-839-9026
Fax: 713-523-6634
Website: www.sullolaw.com